Humana (HUM) Cash & Current Investments (2009 - 2026)

Humana (HUM) has reported Cash & Current Investments for 18 consecutive years, with $23.9 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash & Current Investments rose 9.96% year-over-year to $23.9 billion; the TTM figure through Jun 2026 stood at $23.9 billion (up 9.96% YoY), while the FY2025 annual figure was $19.9 billion, down 2.6% from the prior year.
• Cash & Current Investments rose to $23.9 billion in Q2 2026 per HUM's latest filing, from $22.0 billion in the prior quarter.
• Across five years, Cash & Current Investments topped out at $31.5 billion in Q2 2023 and bottomed at $18.0 billion in Q1 2022.
• Historically, Cash & Current Investments has averaged $23.1 billion across 5 years, with a median of $22.1 billion in 2025.
• Annual changes were most pronounced in 2023 — Cash & Current Investments jumped 72.98% — and 2024, when it dropped 27.14%.
• Humana's Cash & Current Investments stood at $18.9 billion in 2022, then increased by 12.55% to $21.3 billion in 2023, then fell by 4.15% to $20.4 billion in 2024, then declined by 2.6% to $19.9 billion in 2025, then increased by 19.94% to $23.9 billion in 2026.
• Business Quant data shows HUM's Cash & Current Investments at $23.9 billion in Q2 2026, $22.0 billion in Q1 2026, and $19.9 billion in Q4 2025.